53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

Recruiting

Phase 2

TPX-10053-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femoral Osteoarthritis of the Knee

Sponsor:

OrthoTrophix, Inc

Code:

NCT06865079

Conditions

Osteoarthritis (OA) of the Knee

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

TPX-100 200mg, Once weekly for 4 weeks

PBS

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-24. This information was provided to ClinicalTrials.gov by OrthoTrophix, Inc on 2025-10-08.